BioLineRx(BLRX)
Israel - Modi’in
BiotechnologyFocus: Small Molecules, Biologics
BioLineRx is a life sciences company focused on Small Molecules, Biologics.
OncologyNeurologyRare DiseasesInfectious DiseasesImmunology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
1.25 mg/kg BL-8040 + BL-8040-matching placebo
Healthy SubjectsClinical Trials (1)
NCT05293171Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects
Phase 1Motixafortide
Multiple MyelomaClinical Trials (1)
NCT06547112A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization
Phase 1Motixafortide
Sickle Cell DiseaseClinical Trials (1)
NCT02073019A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers
Phase 1BL-1021
HealthyClinical Trials (1)
NCT01121380A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021
Phase 1BL 1020
HealthyClinical Trials (1)
NCT00480246A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
Phase 1BL-8040
Acute Myeloid LeukemiaRibavirin
Hepatitis CClinical Trials (1)
NCT01833845Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in Patients Infected With Hepatitis C
Phase 1/2Morphine
Acute PainClinical Trials (1)
NCT00374881A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human Subjects
Phase 1/25-Fluorouracil
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaBL-7010
Celiac DiseaseClinical Trials (1)
NCT01990885Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients.
Phase 1/2BL-1040
Cardiovascular DiseaseClinical Trials (1)
NCT00557531Safety and Feasibility of the Injectable BL-1040 Implant
Phase 1/2BL-7040
Ulcerative ColitisClinical Trials (1)
NCT01506362Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
Phase 2Cytarabine
Acute Myeloid LeukemiaClinical Trials (1)
NCT02502968BL-8040 Addition to Consolidation Therapy in AML Patients
Phase 2BL-8040
Acute Myelogenous LeukemiaClinical Trials (1)
NCT02639559Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies
Phase 2BL-1020
SchizophreniaClinical Trials (1)
NCT00480571Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
Phase 2BL-1020
SchizophreniaClinical Trials (1)
NCT00722176Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020
Phase 2Phase 2
Clinical Trials (1)
NCT01838395Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients
Phase 2Phase 2
BL-8040
Aplastic AnemiaClinical Trials (1)
NCT02462252Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome
Phase 2BL - 1020
SchizophreniaClinical Trials (1)
NCT00567710A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study
Phase 2CYP-1020
SchizophreniaClinical Trials (1)
NCT01363349Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia
Phase 2/3BL-8040 1.25 mg/kg + G-CSF
Multiple MyelomaClinical Trials (1)
NCT03246529A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 19 clinical trials